Semaphorin3F down-regulates the expression of integrin α vβ3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro

Chenhong Zheng,Qi Zhou,Feng Wu,QiuPing Peng,Airong Tang,Houjie Liang,Yanjun Zeng
DOI: https://doi.org/10.1159/000232449
2009-01-01
Chemotherapy
Abstract:Background: Multicellular resistance (MCR), i.e. decreased sensitivity to anticancer drugs compared with common monolayer cell (MC) cultures, depends partly on tumor cell-cell adhesion. Previous studies have shown that anti-adhesive therapies, including integrin alpha(v), beta(1) and alpha(v)beta(3) targeting, induced apoptosis and reversed the sensitivity of MCR. Methods: A model of three-dimensional cell culture was used to establish HT29 multicellular spheroid cells (MCS) and explore the effect of semaphorin3F (Sema3F) on integrin-mediated cell-cell interactions in MCS of a human colorectal adenocarcinoma cell line (HT29) and sensitization of HT29 MCS to 5-fluorouracil and oxaliplatin via a decrease in integrin alpha(v)beta(3). Results: Elevated expression of Sema3F led to the up-regulation neuropilin-2 (Nrp2) receptor expression and the down-regulation of integrin alpha(v)beta(3) expression. Furthermore, short interfering RNA of Nrp2 could reverse MCR. Conclusion: Our study demonstrates that Sema3F can sensitize MCR by decreasing integrin alpha(v)beta(3) expression via the Nrp2 receptor. Copyright (C) 2009 S. Karger AG, Basel
What problem does this paper attempt to address?